Literature DB >> 21350910

Human urate transporter 1 (hURAT1) mediates the transport of orotate.

Daisaku Miura1, Naohiko Anzai, Promsuk Jutabha, Suparat Chanluang, Xin He, Toshiyuki Fukutomi, Hitoshi Endou.   

Abstract

Orotate is a precursor of pyrimidine synthesis. The kidney uses exogenous orotate for the synthesis of uridine diphosphosugars, which are used in the glycosylation of collagen in glomerular and tubular basement membranes. Orotate uptake occurs in the liver and kidney, but its molecular mechanism is largely unknown. Since orotate has been shown to be a substrate of the renal urate/anion exchanger in brush border membrane vesicle studies, we investigated whether human URAT1 (hURAT1) mediates the transport of orotate using HEK293 cells expressing hURAT1 (HEK-hURAT1). hURAT1 mediated a time- and dose-dependent uptake of orotate (K (m) 5.2 μM). hURAT1-mediated [(3)H]orotate transport was inhibited strongly by non-labeled (cold) orotate and the uricouric agent benzbromarone, and moderately inhibited by urate, nicotinate, and another uricouric agent, probenecid. This is the first report demonstrating that hURAT1 mediates the transport of orotate. hURAT1 may function as one of the entrance pathways in renal proximal tubular cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350910     DOI: 10.1007/s12576-011-0136-0

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  16 in total

1.  Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.

Authors:  Ho Jung Shin; Michio Takeda; Atsushi Enomoto; Masaaki Fujimura; Hiroki Miyazaki; Naohiko Anzai; Hitoshi Endou
Journal:  Nephrology (Carlton)       Date:  2011-02       Impact factor: 2.506

2.  Ribonucleic acid synthesis in the renal cortex at the initiation of compensatory growth.

Authors:  P Cortes; N W Levin; P R Martin
Journal:  Biochem J       Date:  1976-08-15       Impact factor: 3.857

3.  Determination of orotic acid (vitamin B13) in human serum and urine by differential-pulse polarography.

Authors:  L Calvo; J Rodríguez; F Vinagre; A Sánchez
Journal:  Analyst       Date:  1988-02       Impact factor: 4.616

4.  Effects of orotate administration on the normal rat kidney: similarity to changes observed in diabetes mellitus.

Authors:  F Dumler; P Cortes; N W Levin; B H Spargo; A H Rubenstein; C P Verghese
Journal:  Diabetes       Date:  1979-07       Impact factor: 9.461

5.  Differential labeling with orotic acid and uridine in compensatroy renal hypertrophy.

Authors:  J S Ross; D Malamud; J A Caulfield; R A Malt
Journal:  Am J Physiol       Date:  1975-10

6.  Molecular identification of a renal urate anion exchanger that regulates blood urate levels.

Authors:  Atsushi Enomoto; Hiroaki Kimura; Arthit Chairoungdua; Yasuhiro Shigeta; Promsuk Jutabha; Seok Ho Cha; Makoto Hosoyamada; Michio Takeda; Takashi Sekine; Takashi Igarashi; Hirotaka Matsuo; Yuichi Kikuchi; Takashi Oda; Kimiyoshi Ichida; Tatsuo Hosoya; Kaoru Shimokata; Toshimitsu Niwa; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Nature       Date:  2002-04-14       Impact factor: 49.962

7.  The urinary excretion of orotic acid and orotidine, measured by an isotope dilution assay.

Authors:  W J Tax; J H Veerkamp; E D Schretlen
Journal:  Clin Chim Acta       Date:  1978-12-15       Impact factor: 3.786

8.  Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate.

Authors:  Ho Jung Shin; Naohiko Anzai; Atsushi Enomoto; Xin He; Do Kyung Kim; Hitoshi Endou; Yoshikatsu Kanai
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

9.  Relationship between renal function and metabolic alterations in early streptozocin-induced diabetes in rats.

Authors:  P Cortes; F Dumler; J Goldman; N W Levin
Journal:  Diabetes       Date:  1987-01       Impact factor: 9.461

10.  Orotate uptake and metabolism in normal and neoplastic tissues.

Authors:  M A Lea; V Oliphant; A Luke
Journal:  Comp Biochem Physiol B       Date:  1987
View more
  8 in total

Review 1.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Effects of extracellular orotic acid on acute contraction-induced adaptation patterns in C2C12 cells.

Authors:  Thomas Beiter; Jens Hudemann; Christof Burgstahler; Andreas M Nieß; Barbara Munz
Journal:  Mol Cell Biochem       Date:  2018-02-14       Impact factor: 3.396

4.  Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-α in human proximal tubular cells.

Authors:  Kento Kitada; Daisuke Nakano; Hirofumi Hitomi; Hiroyuki Kobori; Kazushi Deguchi; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-10       Impact factor: 2.557

5.  Uric acid crystal could inhibit Numb-induced URAT1 lysosome degradation in uric acid nephropathy.

Authors:  Xinlin Wu; Jianqing Zhang; Taoli Liu; Miansheng Yan; Heng Liu; Hongbo Xie; Shijun Zhang; Baoguo Sun; Bin Ke; Houming Zhou
Journal:  J Physiol Biochem       Date:  2015-03-17       Impact factor: 4.158

Review 6.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31

7.  The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study.

Authors:  Andreas Muehler; Hella Kohlhof; Manfred Groeppel; Daniel Vitt
Journal:  Drugs R D       Date:  2019-12

8.  Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.

Authors:  Jiaju Xu; Yuenan Liu; Jingchong Liu; Yi Shou; Zhiyong Xiong; Hairong Xiong; Tianbo Xu; Qi Wang; Di Liu; Huageng Liang; Hongmei Yang; Xiong Yang; Xiaoping Zhang
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.